Parasitic skin infections: neglected diseases or just challenging for diagnosis?


Journal

Current opinion in infectious diseases
ISSN: 1473-6527
Titre abrégé: Curr Opin Infect Dis
Pays: United States
ID NLM: 8809878

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 29 1 2020
medline: 1 5 2021
entrez: 29 1 2020
Statut: ppublish

Résumé

The aim of the article is to review the most recent evidence concerning parasitic skin infections. Parasitic skin infections are increasingly reported worldwide. Special at-risk categories are migrants, returning travelers, and immunocompromised individuals, who are at higher risk to present disseminated disease. The number of reported cases is growing even outside the endemic areas as a consequence of international travels, migration flows, increasing immunocompromised population, climate change, and natural disasters. Skin parasitoses are neglected infections. Funding assigned to prevent and treat them is limited, even if they affect millions of persons worldwide. Diagnosis could be a challenge for clinicians of high-income countries who are facing an increasing number of such infections related to great epidemiological events.

Identifiants

pubmed: 31990812
doi: 10.1097/QCO.0000000000000634
pii: 00001432-202004000-00005
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-129

Références

World Health Organization. Recognizing neglected tropical diseases through changes on the skin: a training guide for front-line health workers. 2018.
Kanani K, Amr ZS, Shadfan B, et al. Cutaneous leishmaniasis among Syrian refugees in Jordan. Acta Trop 2019; 194:169–171.
Çizmeci Z, Karaku M. Leishmaniasis in Istanbul: a new epidemiological data about refugee leishmaniasis. Acta Trop 2019; 195:23–27.
Eroglu F, Ozgoztasi O. The increase in neglected cutaneous leishmaniasis in Gaziantep province of Turkey after mass human migration. Acta Trop 2019; 192:138–143.
Kaffenberger BH, Shetlar D, Norton SA, Rosenbach M. The effect of climate change on skin disease in North America. J Am Acad Dermatol 2017; 76:140–147.
Dayrit JF, Bintanjoyo L, Andersen LK, Davis MDP. Impact of climate change on dermatological conditions related to flooding: update from the Internatinal Society of Dermatology Climate Change Committee. Int J Dermatol 2018; 57:901–910.
Calvopina M, Aguirre C, Cevallos W, et al. Coinfection of leishmania guyanensis and human immunodeficiency virus-acquired immune deficiency syndrome: report of a case of disseminated cutaneous leishmaniasis in Ecuador. Am J Trop Med Hyg 2017; 96:1151–1154.
Magdalena Alcover M, Rocamora V, Carmen Guillén M, et al. Diffuse cutaneous leishmaniasis by Leishmania infantum in a patient undergoing immunosuppressive therapy: risk status in an endemic Mediterranean area. Am J Trop Med Hyg 2018; 98:1313–1316.
Mondal D, Kumar A, Sharma A, et al. Relationship between treatment regimens for visceral leishmaniasis and development of postkala-azar dermal leishmaniasis and visceral leishmaniasis relapse: a cohort study from Bangladesh. PLOS Negl Trop Dis 2019; 13:e0007653.
Muvdi-Arenas S, Ovalle-Bracho C. Mucosal leishmaniasis: a forgotten disease: description and identification of species in 50 Colombian cases. Biomedica 2019; 39:1–20.
Kutner A, Aldrich M, Patel S, et al. Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient. Transpl Infect Dis 2018; 20:4–7.
Sells RE, Chen CA, Wong MT, et al. Continuous positive airway pressure-associated cutaneous amoebiasis in an immunosuppressed patient. Br J Dermatol 2016; 174:625–628.
Di Meco E, Di Napoli A, Amato LM, et al. Infectious and dermatological diseases among arriving migrants on the Italian coasts. Eur J Public Health 2018; 28:910–916. doi: 10.1093/eurpub/cky126.
doi: 10.1093/eurpub/cky126
Kloning T, Nowotny T, Alberer M, et al. Morbidity profile and sociodemographic characteristics of unaccompanied refugee minors seen by paediatric practices between October 2014 and February 2016 in Bavaria, Germany. BMC Public Health 2018; 18:983doi: 10.1186/s12889-018-5878-7.
doi: 10.1186/s12889-018-5878-7
Lugović-Mihić L. The increase in Croatia's scabies incidence: how did refugees and traveling contribute? Travel Med Infect Dis 2019; 29:74.
Rahdar M, Maraghi S. Norwegian scabies in two immune-compromised patients: a case report. Iran J Public Health 2019; 48:1169–1173.
Ghosh T, Jandhyala D, Bhatti MM, Pritta BS. Crusted scabies in a leukemic patient following a stay in a long-term acute care facility. J Clin Microbiol 2017; 55:1599–1600.
Belvisi V, Orsi GB, Del Borgo C, et al. Large nosocomial outbreak associated with a Norwegian scabies index case undergoing TNF-α inhibitor treatment: management and control. Infect Control Hosp Epidemiol 2015; 36:1358–1360.
Nájera Villagrana SM, García Naranjo Santisteban A. Tungiasis: a highly neglected disease among neglected diseases: case series from Nduta refugee camp (Tanzania). Oxford Med Case Rep 2019; 2019:267–270.
Graveriau C, Peyron F. Cutaneous myiasis. Travel Med Infect Dis 2017; 16:70–71.
Buonfrate D, Baldissera M, Abrescia F, et al. Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014. EuroSurveillance 2016; 21:1–8.
Herrera R, Rojas-contreras C, De la Cruz-ku G, et al. Púrpura por Strongyloides stercoralis en un paciente immunocompetente. Rev Chil Infectol 2018; 35:445–447.
Drago F, Ciccarese G, Brigati C, Parodi A. Strongyloides autoinfection manifesting as Larva currens in an immunocompetent patient. J Cutan Med Surg 2016; 20:617–618.
Pichard DC, Hensley JR, Williams E, et al. Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression. J Am Acad Dermatol 2014; 70:1130–1134.
Merman E, Siddha S, Keystone JS, et al. Cutaneous strongyloides infection postchemotherapy. J Cutan Med Surg 2016; 20:337–339.
Buonfrate D, Salas-Coronas J, Muñoz J, et al. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. Lancet Infect Dis 2019; 19:1181–1190. doi: 10.1016/S1473-3099(19)30289-0.
doi: 10.1016/s1473-3099(19)30289-0
Alam SI, Nepal P, Lu SC, et al. Imaging findings of subcutaneous human dirofilariasis. Curr Probl Diagn Radiol 2019; 5–7. doi:10.1067/j.cpradiol.2019.07.001.
doi: 10.1067/j.cpradiol.2019.07.001
Leroy J, Cornu M, Deleplancque AS, et al. Sushi, ceviche and gnathostomiasis: a case report and review of imported infections. Travel Med Infect Dis 2017; 20:26–30.
Rostami A, Guangxu M, Tao W, et al. Human toxocarisis - A look at a neglected disease through an epidemiological “prism”. Infect Genet Evol 2019; 74:104002.
Recuero KJ, Binda G, Kiszewski AE. Eosinophilic panniculitis associated with toxocariasis in a child. An Bras Dermatol 2019; 94:250–251.
Lancet. Guinea worm disease eradication: a moving target. The Lancet 2019; 393:1261.
De Liberato C, Berrilli F, Bossù T, et al. Outbreak of swimmer's itch in Central Italy: description, causative agent and preventive measures. Zoonoses Public Health 2019; 66:377–381.
Korzeniewski K, Juszczak D, Jerzemowski J. Skin lesions in returning travellers. Int Marit Health 2015; 66:173–180.
Keystone JS. Skin & soft tissue infections in returned travelers. CDC yellow book 2018.
Sikka N, Siev A, Boyer R, Pourmand A. Tungiasis, a rare case of plantar inflammatory disease, a review of travelers skin lesions for emergency providers. Am J Emerg Med 2019; 37:1215.e5–1215.e7.
Ehehalt U, Schunk M, Jensenius M, et al. Leishmaniasis acquired by travellers to endemic regions in Europe: a EuroTravNet multicentre study. Travel Med Infect Dis 2014; 12:167–172.
Gushulak BD. Humanitarian aid workers. CDC yellow book 2018; 597–599.
Pielok Ł, Frąckowiak K, Kłudkowska M. Disseminated skin rash and blood eosinophilia in a Polish traveler diagnosed Strongyloides stercoralis, Trichuris trichiura, Schistosoma sp. and Blastocystis sp. coinfection. Ann Parasitol 2019; 65:99–102.
Boggild AK, Geduld J, Libman M, et al. Spectrum of illness in migrants to Canada: sentinel surveillance through CanTravNet. J Travel Med 2019; 26:1–9.
Greenaway C, Castelli F. Infectious diseases at different stages of migration: an expert review. J Travel Med 2019; 26:1–10.
Isenring E, Fehr J, Gültekin N, Schlagenhauf P. Infectious disease profiles of Syrian and Eritrean migrants presenting in Europe: a systematic review. Travel Med Infect Dis 2018; 25:65–76.
Cheng HM, Kumarasinghe SP. Dermatological problems of asylum seekers arriving on boats: a case report from Australia and a brief review. Australas J Dermatol 2014; 55:270–274.
Burke VE, Lopez FA. Approach to skin and soft tissue infections in non-HIV immunocompromised hosts. Curr Opin Infect Dis 2017; 30:354–363.
Badirzadeh A, Mohebali M, Sabzevari S, et al. First coinfection report of mixed leishmania infantum/leishmania major and human immunodeficiency virus-acquired immune deficiency syndrome: report of a case of disseminated cutaneous Leishmaniasis in Iran. Am J Trop Med Hyg 2018; 98:122–125.
Martínez DY, Verdonck K, Kaye PM, et al. Tegumentary leishmaniasis and coinfections other than HIV. PLoS Negl Trop Dis 2018; 12:1–20.
Meireles CB, Maia LC, Soares GC, et al. Atypical presentations of cutaneous leishmaniasis: a systematic review. Acta Trop 2017; 172:240–254.
Yotsu RR. Integrated management of skin NTDs-lessons learned from existing practice and field research. Trop Med Infect Dis 2018; 3:

Auteurs

Giulia Gardini (G)

University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Brescia, Italy.

Lina Rachele Tomasoni (LR)

University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Brescia, Italy.

Francesco Castelli (F)

University Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili, Brescia, Italy.
UNESCO Chair Training and Empowering Human Resources for Health Development in Resource-Limited Countries.
ESCMID Study Group for Infections in Travelers and Migrants (ESGITM), Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH